在宅患者の爪白癬外用療法の現状

Yoshitaka Yoneta, Yoshihiro Imazu, Emiko Uchida, Katsunori Yamaura, Junko Suzuki

研究成果: Article査読

抄録

Patients usually consult a dermatologist for the treatment of onychomycosis. However, in the case of home care, visiting nurses may assist with bathing, which offers the opportunity to observe patients' feet for possible signs of onychomycosis without causing anxiety. It is estimated that more than 30% of patients receiving home care have onychomycosis. Before the approval of efinaconazole, healthcare personnel hesitated to treat onychomycosis because of: 1) possible side effects, especially liver dysfunction and pain due to repeated blood collection, as a major goal of home care is to minimize pain; and 2) the questionable efficacy of previously available antifungal medications. In addition, many patients report fear of "transmitting athlete's foot to others" and "do not want to show my dirty toenails". On the other hand, caregivers reportedly worry about "athlete's foot being transmitted to them".

寄稿の翻訳タイトルCurrent status of onychomycosis topical therapy conducted at home
本文言語Japanese
ページ(範囲)607-609
ページ数3
ジャーナルYakugaku Zasshi
138
5
DOI
出版ステータスPublished - 2018

Keywords

  • Dermatology
  • Efinaconazole
  • Home care
  • Onychomycosis

ASJC Scopus subject areas

  • 薬理学
  • 薬科学

フィンガープリント

「在宅患者の爪白癬外用療法の現状」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル